×

Risk of Infection from Anti-CD20

Tweet I was at a meeting recently and the manufacturer of a CD20-depleting antibodies had created slides for the speaker that implied that there was no important serious infection risk with their product and I thought this doesn’t really reflect that reported by academics using…

The Blood and Lymph Glands are different

Tweet This study uses a new technique to tell us that the cells in the blood are different to those in the immune organs…it is a bit of a NSS moment for me as we have known this for decades. Cells such as T cells…

How hand weakness led me to a meaningful career in medicine

To call my medical career a series of random pivots is an understatement. I have multiple sclerosis (MS) to thank for this wandering journey, one with an uncertain destination, but a surprisingly meaningful landing place. Anesthesiology was my first love. I adored tinkering with the…

DMTs that protect brain volume may also slow disability progression

Specific disease-modifying therapies (DMTs) significantly slow the rate of brain volume loss in adults with multiple sclerosis (MS), a benefit that is directly linked to reduced long-term disability, according to a new review. A network meta-analysis of more than 26,000 patients confirms that therapies most…

What a mess in defining MS

Tweet Disability accumulation what drives it? Relapse associated worsening (RAW) or progression independent of relapse activity (PIRA). It says here most of it is due to PIRA but PIRA typically covers all worsening about 30 days after a relapse…One can argue that a significant part…

Is this the end of PML? Treating JC virus with antivirals.

Tweet Everybody wants to get rid of EBV and there are a number of trials testing tenofovir alafenamide fumarate (TAF). This current study however reported that Tenofovir targets JC virus and so inhibits the development of PML. So this is good news. NDG treated PML…